Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 212, Issue 3, Pages 307-317
Publisher
Rockefeller University Press
Online
2015-03-03
DOI
10.1084/jem.20140964
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell Cycle-Related Acquisition of Cytotoxic Mediators Defines the Progressive Differentiation to Effector Status for Virus-Specific CD8+ T Cells
- (2014) M. R. Jenkins et al. JOURNAL OF IMMUNOLOGY
- Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning
- (2014) Elena Sieni et al. Frontiers in Immunology
- Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8+ T cells and dendritic cells
- (2013) C. E. Terrell et al. BLOOD
- Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack
- (2013) J. A. Lopez et al. BLOOD
- Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis
- (2013) O Susanto et al. CELL DEATH AND DIFFERENTIATION
- Rapid and Unidirectional Perforin Pore Delivery at the Cytotoxic Immune Synapse
- (2013) J. A. Lopez et al. JOURNAL OF IMMUNOLOGY
- Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells
- (2013) P. J. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Perforinopathy: A Spectrum of Human Immune Disease Caused by Defective Perforin Delivery or Function
- (2013) Ilia Voskoboinik et al. Frontiers in Immunology
- Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737
- (2012) V R Sutton et al. Cell Death & Disease
- In vivo evidence for dendritic cell lysis by NK cells: Hints on improving cancer vaccines by targeting NK cell activation
- (2012) Guido Ferlazzo OncoImmunology
- Familial and Acquired Hemophagocytic Lymphohistiocytosis
- (2011) G.E. Janka Annual Review of Medicine
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
- (2011) Andreas Strasser et al. EMBO JOURNAL
- Dose-dependent effects of the caspase inhibitor Q-VD-OPh on different apoptosis-related processes
- (2011) Kateřina Kuželová et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Critical Role for Granzymes in Antigen Cross-Presentation through Regulating Phagocytosis of Killed Tumor Cells
- (2011) S. Hoves et al. JOURNAL OF IMMUNOLOGY
- The synapse and cytolytic machinery of cytotoxic T cells
- (2010) Misty R Jenkins et al. CURRENT OPINION IN IMMUNOLOGY
- Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice
- (2009) Jana Pachlopnik Schmid et al. EMBO Molecular Medicine
- The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse
- (2009) Misty R. Jenkins et al. IMMUNITY
- Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection
- (2009) G. Yeretssian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity
- (2008) K A Sedelies et al. CELL DEATH AND DIFFERENTIATION
- Cytotoxic T-lymphocyte–mediated killing of human pancreatic islet cells in vitro
- (2008) Peter D. Campbell et al. HUMAN IMMUNOLOGY
- Tumor resistance to apoptosis
- (2008) Simone Fulda INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started